Global Fish Oil EPA and DHA Market Strategic Research Report

Scope of the Report

The global Fish Oil EPA and DHA market size is predicted to grow from US$ 1,704 million in 2025 to US$ 2,132 million in 2032; it is expected to grow at a CAGR of 3.3% from 2026 to 2032.

Fish oil is a kind of oil extracted from fatty fish. It is rich in eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and various n-3 polyunsaturated fatty acids (n-3PUFA), which are essential unsaturated fatty acids for the human body. EPA can clean up blood vessel waste, soften blood vessels and improve immunity, and is known as the "blood vessel scavenger"; DHA is often used for pregnant women and infants. By taking DHA, it can promote the normal growth and development of the brain, thus playing a so-called brain-boosting and intelligence-enhancing effect, commonly known as "brain gold".

Rising Burden of Chronic Diseases Fuels Preventive Nutrition: As cardiovascular diseases, diabetes, neurodegenerative disorders, and systemic inflammation become global public health challenges, demand for preventive and functional nutrition is rising. EPA is well-known for its anti-inflammatory and triglyceride-lowering effects, while DHA supports neural and retinal development. These health benefits position EPA and DHA as essential components of daily supplementation, increasingly recommended by healthcare professionals.

Growing Focus on Cognitive and Brain Health Accelerates DHA Demand: With aging populations and heightened awareness of childhood cognitive development, DHA is gaining traction as a key structural component of the brain and nervous system. DHA supplementation is now routine in prenatal supplements, infant formula, and cognitive support products for aging adults, making it a central growth driver in the omega-3 category.

Expanding Middle Class and Health-Conscious Consumers Boost Uptake: In emerging markets, especially in Asia-Pacific, the expanding middle class and rising health literacy are driving the shift from curative medicine to preventive self-care. Fish oil supplements are increasingly viewed as affordable and accessible wellness investments by families looking to maintain long-term health.

Pharmaceutical-Grade EPA Adoption Reinforces Clinical Value: Prescription EPA products like icosapent ethyl have demonstrated strong clinical benefits in reducing cardiovascular risk. As more regulatory bodies and health systems embrace these results, the pharmaceutical segment is emerging as a high-value growth pillar, pushing the omega-3 industry further into the healthcare domain.

Advancements in Purification Technology Improve Quality and Appeal: Historically, concerns over fishy taste, oxidation, and contamination hindered broader omega-3 adoption. Today, molecular distillation, supercritical CO₂ extraction, and re-esterification techniques have led to purer, better-tasting, and more bioavailable products, greatly enhancing consumer trust and satisfaction.

This report presents a comprehensive overview of the global Fish Oil EPA and DHA market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Fish Oil EPA
• Fish Oil DHA

Segment by Application

• Dietary Supplements
• Fortified Foods and Beverages
• Infant Formula
• Pharmaceuticals
• Pet Foods
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Fish Oil EPA and DHA market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Dietary Supplements, Fortified Foods and Beverages, Infant Formula evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact